Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331938 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Percutaneous SPG Block in Aneurysmal SAH
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT04331938: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT04331938 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04331938, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
Researchers are trying to develop alternative means to help patients with headache pain secondary to aneurysmal subarachnoid hemorrhage (bleeding about the brain).
Interventions
- DRUG Regional anesthetic SPG block-bilateral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2024-04-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04331938
The ClinicalTrials.gov registry entry for NCT04331938 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Regional anesthetic SPG block-bilateral is the first listed.
NCT04331938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04331938 about?
NCT04331938 is a clinical study titled "Efficacy of Percutaneous SPG Block in Aneurysmal SAH". Researchers are trying to develop alternative means to help patients with headache pain secondary to aneurysmal subarachnoid hemorrhage (bleeding about the brain).
What is the current status of trial NCT04331938?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2020-11-01. Estimated completion is 2024-04-08.
What interventions are being tested in trial NCT04331938?
The interventions under investigation include: Regional anesthetic SPG block-bilateral (DRUG).
Who is sponsoring clinical trial NCT04331938?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.